Learn More
Medchemexpress LLC Ginsenoside Rh2 | 78214-33-2 | 622.87 | 25 MG

Supplier: Medchemexpress LLC 25MGHYN0605
Ginsenoside Rh2 is a promising candidate for anti-tumor drug development, promoting cancer cell apoptosis through multiple pathways by activating caspase-8 and caspase-9. It triggers p53-dependent Fas expression and subsequent activation of caspase-8, as well as a p53-independent caspase-9-mediated intrinsic pathway to cause cancer cell death.
- Induces activation of caspase-8 and caspase-9.
- Promotes cancer cell apoptosis in a multi-path manner.
- Triggers p53-dependent Fas expression.
- Activates p53-independent caspase-9-mediated intrinsic pathway.
- Exhibits cytotoxic activity in various human tumor cell lines.
- Shown to reduce tumor sizes and increase survival in animal models.
- Purity of 99.28%.
- Appears as a white to off-white solid.
- Derived from natural sources (Panax ginseng C. A. Meyer).
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.